Pharmacy Daily | Dispensing Di-Gesic

On 1 Jan 2014 the new conditions to promote the safe use of Di-Gesic (dextropropoxyphene HCl 32.5mg / paracetamol 325mg) and Doloxene (dextropropoxyphene napsylate). come into effect (PD Dec 3). From the start of Jan pharmacists now must sight and retain (for 2 years) a Prescriber Confirmation Form each time a first script is dispensed for Di-Gesic or Doloxene. This form will be given to the patient by his/her doctor, but is not required for repeat prescriptions. Pharmacists must also photocopy and retain a de-identified copy of each Di-Gesic or Doloxene prescription dispensed, whether it is a first dispensing or a repeat dispensing. Copies of these prescriptions may be required for audit purposes. Pharmacists who participate in the supply scheme agree to be audited to determine compliance with the new dispensing conditions. A sample of pharmacies will be selected for auditing in certain months and information collected during the audit process will be de-identified. Full details of the Di-Gesic and Doloxene supply scheme along with frequently asked questions can be found on the Aspen Website. Go to www.aspenpharma.com.au and log in from the Secure Access “DPP” dropdown link using the password “ support”. Prior to 01 January 2014 scripts for Di-Gesic and Doloxene should be handled in the usual manner.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 06 Dec 13
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Dec 13